Viewing Study NCT05332834


Ignite Creation Date: 2025-12-25 @ 2:32 AM
Ignite Modification Date: 2026-03-03 @ 4:32 AM
Study NCT ID: NCT05332834
Status: COMPLETED
Last Update Posted: 2024-09-27
First Post: 2022-03-31
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 1 Study of Single and Multiple Intravenous Doses of SM17 in Healthy Subjects
Sponsor: SinoMab BioScience Ltd
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Asthma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None SM17 View